Bain Capital Life Sciences acquires 9.99% stake in ADC Therapeutics
Bain Capital Life Sciences Opportunities IV, L.P. reports a 9.99% stake in ADC Therapeutics SA, indicating strategic investment in the pharmaceutical sector.
Studio City International Holdings reports major share transactions
Studio City International Holdings Ltd sees significant share transactions from major stakeholders, indicating strong investment interest in the hospitality sector.
Saba Capital Management acquires shares in New Germany Fund
Saba Capital Management, L.P. acquires 2,504 shares of New Germany Fund Inc., signaling continued investment in the asset management sector.
Karen L. Carnahan Reports Stock Transactions for Cintas Corp
Karen L. Carnahan disclosed stock transactions involving Cintas Corp, highlighting her ongoing commitment to the company and its market position.
Carmichael Beverly K Reports Stock Transactions in Cintas Corp
Carmichael Beverly K's recent SEC filing reveals stock transactions involving Cintas Corp, highlighting executive compensation trends in the industry.
Ning Hongjun Reports Stock Transactions Involving Unifi Inc.
Ning Hongjun disclosed stock transactions involving Unifi Inc., reflecting changes in executive compensation in the textile manufacturing industry.
Mucci Martin Acquires Shares in Cintas Corp.
Mucci Martin reports share acquisition in Cintas Corp, signaling insider engagement in the men's and boys' furnishings industry.
Fortress Biotech reports 6.5% stake by Integrated Core Strategies
Fortress Biotech, Inc. reveals a 6.5% stake held by Integrated Core Strategies in a recent SEC filing, signaling potential shifts in shareholder dynamics.
Saba Capital Management acquires shares in BNY Mellon fund
Saba Capital Management, L.P. reports acquisition of shares in BNY Mellon Strategic Municipal Bond Fund, indicating ongoing investment strategies.
Saba Capital Management boosts stake in Japan Smaller Capitalization Fund
Saba Capital Management has increased its investment in Japan Smaller Capitalization Fund, reflecting confidence in the fund's future potential.
CCC Intelligent Solutions to be Acquired by GTCR and Elliott
CCC Intelligent Solutions is set to be acquired by GTCR and Elliott, aiming to enhance AI capabilities and expand its network in the prepackaged software industry.
T3 Defense Inc. Calls Special Meeting to Vote on Key Proposals
T3 Defense Inc. announces a special meeting to discuss an equity incentive plan and reverse stock splits, aiming to enhance shareholder value.
BTC Digital Ltd. reports no shares owned by Bigger Capital Fund
BTC Digital Ltd. reveals in SEC filing that Bigger Capital Fund L P owns no shares, impacting ownership dynamics in the finance services sector.
HF Sinclair CEO Franklin Myers Acquires 10,000 Shares
HF Sinclair Corp's CEO Franklin Myers has purchased 10,000 shares of the company, reflecting confidence in its future amid industry dynamics.
Zoomcar Holdings raises $75,000 in new funding agreement
Zoomcar Holdings, Inc. secures $75,000 through a new securities purchase agreement as part of a larger funding effort to raise up to $5 million.
Dine Brands Global adopts stockholder rights agreement
Dine Brands Global, Inc. adopts a stockholder rights agreement to protect against hostile takeovers, marking a significant move in the retail-eating places industry.
T3 Defense raises $10 million through private placement
T3 Defense Inc. secures $10 million from private placement of preferred stock and warrants, enhancing its competitive edge in management consulting.
Estrella Immunopharma appoints Cynthia Pussinen as CEO
Cynthia Pussinen has been appointed as CEO of Estrella Immunopharma, signaling a leadership shift in the biological products industry.
Lattice Strategies Trust proposes merger with Hartford Mutual Funds
Lattice Strategies Trust files for a merger with Hartford Mutual Funds II, potentially reshaping the investment landscape.
Rallybio CEO Uden Acquires 33,244 Shares of Common Stock
Rallybio Corp's CEO Stephen Uden acquires 33,244 shares at $6.08 each, signaling confidence in the company's future and impacting the pharmaceutical preparations sector.